A multicenter randomized controlled study of antioxidant supplementation with lutein for chronic central serous chorioretinopathy

Shinojima A., Sawa M., Sekiryu T., Oshima Y., Mori R., Hara C., Sugano Y., Kato A., Asato H., Yuzawa M., Gomi F., Ogura Y., Ishibashi T., Nanri T., Yasukawa T.

2017
Ophthalmologica

View publication

Therapeutic Area

Back of the eye (BOTE)
Categories

Clinical development

Affiliations

Division of Ophthalmology, Department of Visual Sciences, Nihon University School of Medicine, Tokyo, Japan; Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima, Japan; Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan; Santen Pharmaceutical Co., Ltd., Osaka, Japan

Related Publications

Epidemiology and burden of mild/moderate versus high myopia in Germany: A claims data analysis

Garcia TB, Kossack N, Pignot M, Dagher M, Schuster AK, Wielink KS.

Functional significance of commonly regulated genes in mechanically and chemically induced retinal ganglion cell death in rat eyes

Kageyama M, Ohashi K, Ota T.

Valosin-containing protein modulator KUS121 protects retinal neurons in a rat model of anterior ischemic optic neuropathy

Kikkawa C., Ikeda H.O., Hata M., Iwai S., Tsujikawa A.